As of 2026-03-23, the Relative Valuation of Mirati Therapeutics Inc (MRTX) is (221.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.70 USD, the upside of Mirati Therapeutics Inc based on Relative Valuation is -478.1%.
The range of the Relative Valuation is (204.05) - (247.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 23.9x | 21.8x |
| Forward P/E multiples | 19.7x - 24.4x | 21.1x |
| Fair Price | (204.05) - (247.10) | (221.95) |
| Upside | -447.6% - -521.0% | -478.1% |
| Date | P/E |